» Articles » PMID: 37171806

The Plasma Cell Infiltrate Populating the Muscle Tissue of Patients with Inclusion Body Myositis Features Distinct B Cell Receptor Repertoire Properties

Overview
Journal Immunohorizons
Date 2023 May 12
PMID 37171806
Authors
Affiliations
Soon will be listed here.
Abstract

Inclusion body myositis (IBM) is an autoimmune and degenerative disorder of skeletal muscle. The B cell infiltrates in IBM muscle tissue are predominantly fully differentiated Ab-secreting plasma cells, with scarce naive or memory B cells. The role of this infiltrate in the disease pathology is not well understood. To better define the humoral response in IBM, we used adaptive immune receptor repertoire sequencing, of human-derived specimens, to generate large BCR repertoire libraries from IBM muscle biopsies and compared them to those generated from dermatomyositis, polymyositis, and circulating CD27+ memory B cells, derived from healthy controls and Ab-secreting cells collected following vaccination. The repertoire properties of the IBM infiltrate included the following: clones that equaled or exceeded the highly clonal vaccine-associated Ab-secreting cell repertoire in size; reduced somatic mutation selection pressure in the CDRs and framework regions; and usage of class-switched IgG and IgA isotypes, with a minor population of IgM-expressing cells. The IBM IgM-expressing population revealed unique features, including an elevated somatic mutation frequency and distinct CDR3 physicochemical properties. These findings demonstrate that some of IBM muscle BCR repertoire characteristics are distinct from dermatomyositis and polymyositis and circulating Ag-experienced subsets, suggesting that it may form through selection by disease-specific Ags.

Citing Articles

Inclusion body myositis and immunosenescence: current evidence and future perspectives.

Allameen N, Salam S, Reddy V, Machado P Rheumatology (Oxford). 2024; 64(3):952-961.

PMID: 39504446 PMC: 11879327. DOI: 10.1093/rheumatology/keae614.


Intramyocardial fatty infiltration lesion in sporadic inclusion body myositis: a case report.

Redzepi B, Theaudin M, Bengueddache S, Petropoulou-Natsou S, Masi A, Rodrigues D Int J Cardiovasc Imaging. 2024; .

PMID: 39466494 DOI: 10.1007/s10554-024-03271-z.


Inclusion body myositis, viral infections, and TDP-43: a narrative review.

Vacaras V, Vulturar R, Chis A, Damian L Clin Exp Med. 2024; 24(1):91.

PMID: 38693436 PMC: 11062973. DOI: 10.1007/s10238-024-01353-9.


Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging.

Guglielmi V, Cheli M, Tonin P, Vattemi G Int J Mol Sci. 2024; 25(5).

PMID: 38473988 PMC: 10932328. DOI: 10.3390/ijms25052742.

References
1.
Bradshaw E, Orihuela A, McArdel S, Salajegheh M, Amato A, Hafler D . A local antigen-driven humoral response is present in the inflammatory myopathies. J Immunol. 2006; 178(1):547-56. DOI: 10.4049/jimmunol.178.1.547. View

2.
McIntyre D, S Zuckerman N, Field M, Mehr R, Stott D . The V(H) repertoire and clonal diversification of B cells in inflammatory myopathies. Eur J Immunol. 2013; 44(2):585-96. DOI: 10.1002/eji.201343315. View

3.
Goyal N, Coulis G, Duarte J, Farahat P, Mannaa A, Cauchii J . Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells. Neurology. 2022; 98(13):e1374-e1383. PMC: 8967422. DOI: 10.1212/WNL.0000000000200013. View

4.
Jiang R, Fichtner M, Hoehn K, Pham M, Stathopoulos P, Nowak R . Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses. JCI Insight. 2020; 5(14). PMC: 7453893. DOI: 10.1172/jci.insight.136471. View

5.
Kubo K, Yamamoto K . IgG4-related disease. Int J Rheum Dis. 2015; 19(8):747-62. DOI: 10.1111/1756-185X.12586. View